Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of ...

Gram-positive bacteria show blue or purple after Gram-staining in a laboratory test. They have thick cell walls. Gram-negative bacteria show pink or red on staining and have thin walls. They ...

Antibiotics are overused by some and out of reach for others - fuelling resistance and leaving deadly gaps in care.

Antimicrobial resistance directly causes more than 1 million deaths every year and contributes to more than 35 million more, ...

If successful, it would be the first new class of drug against certain bacteria strains for more than 50 years ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

Antimicrobial resistance directly causes more than 1 million deaths every year and contributes to more than 35 million more, ...